(3S,4S)-3-((R)-(tert-Butyldimethyl-silyloxy)ethyl)-4((R)-carboxyethyl)-2-azetidinone
CAS: 90776-58-2
Ref. 3D-FB149807
5g | 136,00 € | ||
10g | 189,00 € | ||
25g | 341,00 € | ||
50g | 479,00 € | ||
100g | 641,00 € |
Información del producto
- (3S,4S)-4-[(R)-1-carboxyethyl]-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinonebeta-Methylazetidin-2-one
- (2R)-2-{(2S,3S)-3-[(1R)-1-{[tert-butyl(dimethyl)silyl]oxy}ethyl]-4-oxoazetidin-2-yl}propanoic acid
- (3S 4S)-3-[(R)-1-(T-Butyldimethylsilyloxy)Ethyl]-4-[(R)-1-Carboxyethyl]-2-Azetidinone
- (3S,4S)-3-[(1R)-1-[(tert-Butyldimethylsilyl)oxy]ethyl]-4-((1R)-1-carboxyethyl)azetidin-2-one
- (3S,4S)-3-[(R)-(Butyldimethylsilyloxy)Ethyl]-4-[(R)-Carboxyethyl]-2-Azetidinone
- (3S,4S)-3-[(R)-1-(Tert-Butyldimethylsiloxy)Ethyl]-4-[(R)-1-Carboxyethyl]-2-Azetidinone
- (3S,4S)-3-[(R)-1-(Tert-Butyldimethylsilyloxy)Ethyl]-4-[(R)-1-Carboxyethyl]-2-Azetidinone
- (3S,4S)-4-[(R)-1-carboxy-ethyl]-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinone
- (3S,4S)-4-[(R)-1-carboxyethyl]-3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-azetidinone
- (R)-2-((2S,3S)-3-((R)-1-(Tert-Butyldimethylsilyloxy)Ethyl)-4-Oxoazetidin-2-Yl)Propanoic Acid
- Ver más sinónimos
- (R)-2-[(3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-2-oxoazetidin-4-yl]propionic acid
- (αR,2S,3S)-3-[(1R)-1-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-α-methyl-4-oxo-2-azetidineacetic acid
- 1-Bma
- 2-Azetidineacetic acid, 3-[(1R)-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-α-methyl-4-oxo-, (αR,2S,3S)-
- 2-Azetidineacetic acid, 3-[1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-α-methyl-4-oxo-, [2S-[2α(S*),3β(S*)]]-
- 4-BMA(for Meropenem)
- 4-Bma
- 4Bma
- Side Chain For Imipenem
- [2R-[2α(R*),3β(R*)] ]-3-[1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-α-methl-4-oxo-2-azetidineacetic acid
- Β-Methylazetidin-2-One
(3S,4S)-3-((R)-(tert-Butyldimethyl-silyloxy)ethyl)-4((R)-carboxyethyl)-2-azetidinone (SBET) is a propionylated carbapenem antibiotic. It is an analog of ertapenem, a carbapenem antibiotic that has been developed for the treatment of multidrug resistant Gram-negative bacteria. SBET has been shown to have stereospecificity in vitro studies and to be metabolized by organic acids. The reaction yields are dependent on the solvents used. The functional groups on SBET are important for its activity as a carbapenem antibiotic.
Propiedades químicas
Consulta técnica sobre: 3D-FB149807 (3S,4S)-3-((R)-(tert-Butyldimethyl-silyloxy)ethyl)-4((R)-carboxyethyl)-2-azetidinone
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.